Completed

Neuropsychological Evaluation of Psychiatric and Neurological Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Anxiety Disorders+14

+ Behavior

+ Mental Disorders

Until 95 Years
See all eligibility criteria
How is the trial designed

Observational
Study Start: October 1983
See protocol details

Summary

Principal SponsorNational Institute of Mental Health (NIMH)
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 18, 1983

Actual date on which the first participant was enrolled.

Neuropsychological tests are used to provide an assessment of cognitive functions in patients with idiopathic generalized epileptic (IGE) disorders and their first-degree relatives. The battery comprises tests designed to tap attention, memory, selected sensory and perceptual functions, vigilance, and visual-spatial functions. Modified batteries have been developed for the assessment of children ages 5-8, and children ages 8-16. The data provided by these batteries are compared with genetic profiles of the same participants that have been ascertained from blood samples analyzed by colleagues at the Mount Sinai School of Medicine/Columbia University in New York City.

Official TitleNeuropsychological Evaluation of Psychiatric and Neurological Patients
NCT00001192
Principal SponsorNational Institute of Mental Health (NIMH)
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

4300 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Until 95 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Anxiety DisordersBehaviorMental DisordersCommunicationCraniocerebral TraumaLanguageMotor ActivityNervous System DiseasesNeurologic ManifestationsSchizophreniaSeizuresSigns and SymptomsPathological Conditions, Signs and SymptomsWounds and InjuriesMood DisordersSchizophrenia Spectrum and Other Psychotic DisordersTrauma, Nervous System

Criteria

* INCLUSION CRITERIA: Patients. Normal volunteers. EXCLUSION CRITERIA: Subjects over 95 years of age. Subjects with a history of alcohol or drug abuse, psychopathology, or central nervous system pathology, other than that which defines group membership, may be excluded.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 7 locations

Suspended

Childrens National Medical Center

Washington D.C., United StatesOpen Childrens National Medical Center in Google Maps
Suspended

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, United States
Suspended

Henry Ford Health Systems

Detroit, United States
Suspended

Mt. Sinai Medical Center

New York, United States
Completed7 Study Centers